Lab-Grown Gotu Kola Could End the Wild-Harvest Crisis for a Multi-Billion Dollar Skincare Ingredient

Gotu kola, the humble creeping herb known scientifically as Centella asiatica, has quietly become one of the most sought-after plants on the planet. Its leaves contain a family of triterpenoid saponins called centellosides—including asiaticoside, madecassoside, asiatic acid, and madecassic acid—that drive wound healing, neuroprotection, and antioxidant defenses. The cosmetics industry alone has built a market worth roughly 790 million US dollars in 2024, projected to reach 1.2 billion dollars by 2030. Yet a new comprehensive review published in Discover Plants by Amar Hundare and Neelu Joshi argues that the supply chain feeding this demand is fragile, inconsistent, and in places actively harmful to both ecosystems and consumers. Their assessment synthesizes research from 2019 through 2025 and charts a biotechnological roadmap that could take centelloside production out of swamps and into bioreactors.

The problem begins with how C. asiatica is currently sourced. Wild harvesting remains the dominant supply model, and the review documents staggering variability: centelloside content in wild populations fluctuates up to five- to ten-fold depending on geography, environment, and harvest timing. Because the plant naturally favors swamp and marsh ecosystems, wild-collected material faces elevated risks of heavy metal contamination, pathogen exposure, and adulteration. Field surveys in Peninsular Malaysia found significant accumulation of cadmium, copper, nickel, lead, and zinc in wild-harvested gotu kola, with estimated daily intakes suggesting potential lead toxicity risk from plants gathered at polluted sites. Standards bodies such as the World Health Organization expect high-quality herb to contain at least two percent triterpene saponins, while the European Scientific Cooperative on Phytotherapy reports saponin and sapogenin content ranging from one to eight percent—a spread that makes quality control a persistent headache for phytopharmaceutical manufacturers.

Cultivation has not solved the problem either. The review highlights a paradox familiar to anyone working with medicinal plants: more biomass does not mean more medicine. Unlike conventional crops where yield predicts output, C. asiatica can produce lush growth while delivering disappointingly dilute metabolite profiles. Multiple factors shape both growth and centelloside accumulation, including cultivation system, propagation method, light regime, genotype, soil type, farming practice, and even the ploidy status of planting material. Researchers exploring aquaponics, co-cultivation with the root endophyte Piriformospora indica, and polyhouse cultivation of rooted cuttings have reported cultivar-specific differences and dynamic metabolite trends, reinforcing the need for extensive genotypic screening before any field program can deliver consistent quality.

This is where plant tissue culture enters the picture. Callus cultures initiated from leaves, petioles, and nodal segments using auxins such as 2,4-dichlorophenoxyacetic acid and naphthaleneacetic acid, often paired with cytokinins like benzylaminopurine, have reliably produced triterpenoid- and flavonoid-rich biomass. Cell suspension cultures and hairy root cultures—induced through transformation with Agrobacterium rhizogenes—have emerged as the most scalable platforms because they grow rapidly in liquid media, remain genetically stable, and do not require exogenous hormones. Notably, Baek and colleagues demonstrated that petiole-derived hairy roots produced 1.4 times more triterpenoids than leaf-derived lines, a reminder that even the choice of starting explant can decisively shape biosynthetic output. In suspension cultures, asiaticoside accumulation peaked at 1.7-fold above baseline between 21 and 25 days of culture.

The heart of the review is a systematic comparison of elicitation strategies, and the numbers are striking. Methyl jasmonate, the field’s workhorse elicitor, increased asiaticoside by 494 percent in cell suspensions, by 5.6- to 71-fold in hairy roots, and by 69-fold in callus, depending on genotype and treatment conditions. Coronatine delivered 116 milligrams per gram dry weight of madecassoside in elicited hairy roots at day 14 post-elicitation—one of the highest absolute yields ever reported. But the authors issue a crucial warning about the so-called fold-increase paradox: a two-fold rise from a 20 milligram per gram baseline yields 40 milligrams per gram, which is pharmaceutically far more relevant than a 50-fold rise from 0.1 milligrams per gram yielding just 5. Tetraploid hairy roots responded more dramatically to methyl jasmonate than diploid lines, likely because their untreated controls were extremely low to begin with. Heavy metal elicitors such as cadmium and lead could drive 24- and 49-fold increases in asiaticoside and madecassoside respectively, but the authors dismiss these as unusable for pharmaceutical production because of phytotoxicity and contamination risk.

Among biotic elicitors, the toolkit is expanding rapidly. Yeast extract delivered a 3.5-fold boost in asiaticoside, chito-oligosaccharide achieved a five-fold increase in hairy roots at 30 parts per million, and pectin raised asiaticoside content by 31 percent in callus cultures. Endophytic symbionts add another layer of sophistication: Piriformospora indica colonization triggered a 2.5-fold increase in asiaticoside through activation of root-associated stress responses, while rhizobacteria such as Azospirillum and Pseudomonas promote triterpenoid biosynthesis by stimulating jasmonic acid and ethylene signaling pathways. Combined elicitor treatments—methyl jasmonate plus salicylic acid, or coronatine plus methyl jasmonate—consistently outperform single agents, suggesting synergistic activation of jasmonate- and salicylate-dependent signaling, though optimal ratios and staged application sequences remain largely untested.

Beyond elicitation, the review maps several emerging enhancement strategies. Precursor feeding with squalene at 2.5 micromolar boosted total triterpenoids 3.1-fold to 57.53 milligrams per gram dry weight, while higher concentrations triggered feedback inhibition—a classic concentration-dependent regulatory signature. Pyruvic acid supplementation increased triterpenoids 1.9-fold with preferential enhancement of madecassoside. Cell permeability enhancement through ultrasound-assisted extraction has proven remarkably effective: optimized conditions yielded 83.14 milligrams per gram of asiatic acid and 19.71 milligrams per gram of asiaticoside, and combining ultrasound with natural deep eutectic solvents pushed asiaticoside recovery to 229.92 milligrams per gram. Reversible electroporation could theoretically enable repeated, non-destructive metabolite harvesting from viable cultures, transforming batch processes into semi-continuous bioreactor-compatible systems—though this remains untested in C. asiatica.

The genomic era is now catching up with the chemistry. A haplotype-resolved genome assembly published in The Crop Journal confirmed that CaCYP716C11 catalyzes the conversion of 23-hydroxyursolic acid to asiatic acid, and identified CaUGT73CL69 as a glucosyltransferase that converts asiatic acid and madecassic acid to their respective monoglucosides. Tandem duplicate clusters of CaUGT73 genes on chromosome 8 reveal that gene duplication and neofunctionalization have shaped the plant’s glycosylation capacity. Earlier transcriptomic work flagged CaHDR1, CaIDI2, and CaβAS1 as key regulators, while UGT73AH1 and the glycosyltransferases CaUGT73C7 and CaUGT73C8 appear to catalyze the rate-limiting steps that assemble the characteristic sugar chains of asiaticoside and madecassoside. Yet the review’s authors caution that transcript abundance establishes correlation rather than causation, and no peer-reviewed study has yet reported CRISPR/Cas9-mediated editing of centelloside biosynthetic genes in this species.

Scale-up remains the field’s stubborn bottleneck. A 5-liter stirred bioreactor achieved 60.08 milligrams per gram dry weight of asiaticoside with optimized agitation and aeration, while a Plantform temporary immersion system combined with methyl jasmonate elicitation delivered centelloside levels 2.8-fold higher than elicited shake flasks—and 12.2-fold higher than untreated controls. A twin-bottle temporary immersion system more than tripled biomass compared to conventional semi-solid culture, though it did not quantify centellosides. Hairy root cultures, despite their biosynthetic promise, resist scale-up because their dense branching architecture and sensitivity to mechanical stress limit mass transfer. The review identifies mist reactors, wave-mixed bioreactors, and low-shear stirred tanks as untested but promising alternatives. On the translational front, preliminary estimates suggest bioreactor production only becomes economically competitive when centelloside yields exceed 5 percent dry weight and process volumes surpass 500 liters—thresholds that current elicited cultures approach but rarely achieve.

Perhaps the most forward-looking suggestion concerns extracellular vesicles. Membrane-bound nanoparticles secreted by C. asiatica cell cultures have recently been characterized and shown to carry high levels of polyphenols, reduce intracellular reactive oxygen species, suppress pro-inflammatory genes such as COX2, and promote skin repair by inhibiting tyrosinase activity and upregulating barrier-related genes including filaggrin and aquaporin-3. These vesicles outperformed conventional cell culture extracts in stability, cellular uptake, and precision. Because centellosides are packaged during vesicle biogenesis from the endomembrane system, elicited suspension cultures may serve as a platform for generating centelloside-enriched vesicles directly—skipping the extraction step entirely. Combined with the review’s proposed research framework, which prioritizes complete pathway elucidation, enzyme characterization, and systems-level regulatory mapping before engineering intervention, the picture that emerges is one of a field standing at an inflection point: the biological machinery is increasingly understood, the culture platforms are proven, and the remaining gaps—functional validation of candidate genes, standardized elicitor dosing, and validated industrial-scale bioprocesses—are now clearly defined targets rather than open questions.

Subject of Research: Centelloside biosynthesis enhancement in tissue cultures of Centella asiatica

Article Title: Advancements on centelloside biosynthesis in tissue cultures of Centella asiatica (L.) Urban

Article References: Hundare, A., & Joshi, N. (2026). Advancements on centelloside biosynthesis in tissue cultures of Centella asiatica (L.) Urban. Discover Plants, 3(1), Article 396. https://doi.org/10.1007/s44372-026-00867-8

Image Credits: AI Generated

DOI: 10.1007/s44372-026-00867-8

Keywords: Centella asiatica, centellosides, asiaticoside, madecassoside, plant tissue culture, hairy root cultures, elicitation, methyl jasmonate, bioreactor, metabolic engineering, CRISPR, extracellular vesicles